Milena Milivojević, PhD, graduated from the Faculty of Biology at the University of Belgrade in 2005, earning a degree in Molecular Biology and Physiology. She completed her PhD at the same faculty in 2014, where her doctoral dissertation focused on analyzing the role of the Sonic Hedgehog (SHH) signaling pathway in regulating SOX18 gene expression in cervical carcinoma cells. Since 2006, she has been employed at the IMGGE, working within the Human Molecular Genetics Group. Her primary research interests include understanding the molecular mechanisms that regulate tumor development and progression, as well as establishing and implementing 3D model systems to study the malignant potential of tumors. Dr. Milivojević is a member of the Serbian Society for Molecular Biology and the European Association for Cancer Research (EACR). She has participated in 12 national and international scientific projects. Currently, she is the Work Package Leader for the project "Biomimetic Tumor Engineering to Enhance Drug Discovery (BioengineeredTumor)", which is part of the PRISMA program funded by the Science Fund of the Republic of Serbia.